Position
Squarepoint Ops LLC in Myriad Genetics Inc
Back to the book · All holders of MYGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$567.2K$6.15 → $4.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 343.7K | $2.11M | — | — | — | 0.0% |
| Q1 2026 | 517K | $2.33M | $4.50 | −$567.2K | $779.6K | 0.0% |